Inhibitor Research Hub

Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 3-Deazaneplanocin (DZNep): Advanced Epigenetic Modulation...

    2026-01-21

    Explore how 3-Deazaneplanocin (DZNep), a potent S-adenosylhomocysteine hydrolase inhibitor, is redefining epigenetic modulation by targeting EZH2 and histone H3K27 trimethylation. This in-depth analysis uniquely examines DZNep's role in overcoming tumor heterogeneity and advancing translational oncology research.

  • (Z)-4-Hydroxytamoxifen: Reliable Solutions for Cell Assay...

    2026-01-20

    This article guides biomedical researchers and laboratory technicians through practical scenarios where (Z)-4-Hydroxytamoxifen (SKU B5421) from APExBIO addresses core challenges in cell viability, proliferation, and cytotoxicity assays. Scenario-based Q&A blocks provide evidence-driven insights on selectivity, assay optimization, data interpretation, and vendor reliability—grounded in literature and real-world protocols to support superior experimental outcomes.

  • Caspase-3/7 Inhibitor I: Precision Isatin Sulfonamide Cas...

    2026-01-20

    Caspase-3/7 Inhibitor I is a highly selective, reversible isatin sulfonamide inhibitor for caspase-3 and -7, enabling robust apoptosis inhibition in cellular models such as Jurkat cells. Its nanomolar potency and cell-permeable profile make it an indispensable tool for dissecting caspase signaling pathways in cancer, infectious, and neurodegenerative disease research.

408 records 28/28 page Previous First page 上5页 262728